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Background: Melioidosis is an infection caused by the facultative intracellular gram-negative bacterium;
Burkholderia pseudomallei. It gives rise to protean clinical manifestations and has a varied prognosis. Although
it was rare in Sri Lanka increasing numbers of cases are being reported with high morbidity and mortality.
Here we report a case of melioidosis presenting with lymphadenitis which was diagnosed early and treated
promptly with a good outcome.
Case presentation: A 53-year-old Sinhalese woman with diabetes presented with fever and left sided painful
inguinal lymphadenitis for one month. She had undergone incision and drainage of a thigh abscess three months
previously and had been treated with a short course of antibiotics. There was no record that abscess material was
tested microbiologically.
She had neutrophil leukocytosis and elevated inflammatory markers. Initial pus culture revealed a scanty growth
of “Pseudomonas sp.” and Escherichia coli which were sensitive to ceftazidime and resistant to gentamicin.
Due to the history of diabetes, recurrent abscess formation and the suggestive sensitivity pattern of the bacterial
isolates, we actively investigated for melioidosis. The bacterial isolate was subsequently identified as B. pseudomallei
by polymerase chain reaction and antibodies to melioidin antigen were found to be raised at a titre of 1:160.
The patient was treated with high dose intravenous ceftazidime for four weeks followed by eradication therapy
with cotrimoxazole and doxycycline. As the patient was intolerant to cotrimoxazole, the antibiotics were changed
to a combination of co-amoxyclav and doxycycline and continued for 12 weeks. The patient was well after 6 months
without any relapse.
Conclusions: Melioidosis is an emerging infection in South Asia. It may present with recurrent abscesses. Therefore
it is very important to send pus for culture whenever an abscess is drained. However, it should be noted that the
reporting laboratory may be unfamiliar with this bacterium and the isolate may be misidentified as Pseudomonas
or even E. coli. Melioidosis should be suspected when an isolate with the typical antibiotic sensitivity pattern of
ceftazidime sensitivity and gentamicin resistance is cultured, especially in a patient with diabetes. This will expedite
diagnosis and prompt treatment leading to an excellent prognosis.
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Melioidosis is an infection caused by the facultative intracel-
lular gram-negative bacterium; Burkholderia pseudomallei.
Clinical features of melioidosis are highly variable. They
range from asymptomatic disease, localized skin ulcers or
abscesses and acute fulminant septicaemia to chronic
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chronic lung disease and alcoholism [1-3]. Infection
spreads by percutaneous inoculation, inhalation, or inges-
tion. Melioidosis is endemic in tropical and subtropical
zones of South East Asia and Northern Australia [1,2].
Although it is rare in Sri Lanka, increasing numbers of
cases are being reported [4-10] and many of them were
fatal [4-6,9]. Timely diagnosis and prompt institution of
correct antibiotics will prevent high morbidity and mortal-
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treated aggressively with a very good prognosis.
Case presentation
A 53-year-old Sinhalese woman from Chilaw in the North
Western Province of Sri Lanka, presented with intermit-
tent high fever with chills for one month and a painful left
inguinal mass for two weeks. She had diabetes.
She had undergone an incision and drainage of a left
deep thigh abscess three months previously and had been
treated with a short course of antibiotics. There was no
record that abscess material was tested microbiologically.
On examination, she was febrile with the temperature of
103°F. She had a tender, fluctuant mass in the left inguinal
region. The rest of the examination was unremarkable.
There was a raised erythrocyte sedimentation rate (ESR)
of 80 mm in the first hour and a very high C-reactive
protein (CRP) level of 208 mg/dl. The white cell count
was 19 × 109/L with 75% neutrophils. Liver function and
renal function were normal. Ultrasound scan revealed a
left inguinal abscess. Excision biopsy of the abscess was
done and samples were sent for histology, bacterial culture
and antibiotic sensitivity testing, microscopy for acid fast
bacilli and culture for tuberculosis.
Histology revealed chronic lymphadenitis with perinodal
abscess formation. There were no acid fast bacilli in
the direct smear. Initial culture results showed a scanty
growth of Pseudomonas sp. and E. coli which was sensitive
to ceftazidime and treatment commenced according to
the sensitivity pattern.
However, since the Pseudomonas isolate was resistant
to gentamicin and the patient had a history of recurrent
abscess formation, melioidosis was considered in the
differential diagnosis and the bacterial isolates were sent
to the Department of Microbiology, Faculty of Medicine,
University of Colombo for identification.
Bacterial colonies on blood agar were pin point in size
after overnight incubation developing into 1-2 mm, white,
umbonate colonies after 48 hours. On MacConkey agar
the isolate was salmon pink, which may account for the
erroneous conclusion that the “Pseudomonas” isolate was
mixed with E.coli. The colonies had the characteristic
musty, earthy odour of B. pseudomallei and were slowly
oxidase positive. Gram stain appearance revealed the
typical safety pin appearance. The isolate was resistant
to gentamicin, polymyxin and colisitin and sensitive
to co-amoxyclav. Subcultures of the isolate were cour-
iered to a reference laboratory where they were confirmed
as B. pseudomallei by polymerase chain reaction (PCR).
Serum antibodies to melioidin antigen using an in-house
indirect haemagglutination (IHA) test based on that de-
scribed by Alexander et al. with antigen prepared from
local strains of B.pseudomallei [11] were positive at a titre
of 1:160.After confirmation of the diagnosis of melioidosis, it
was decided to treat her with intravenous ceftazidime
for four weeks. There was excellent clinical improve-
ment with normalization of markers of inflammation.
Eradication therapy with oral co-trimoxazole and doxy-
cycline was started on the third week, overlapping with
the intravenous ceftazidime for one week. The patient
tolerated the medications well.
The patient was discharged after completion of four
weeks of intravenous ceftazidime with a plan to continue
oral antibiotics for 12 weeks. However she presented to
the outpatient follow up 2 weeks after discharge with an
itchy rash which was presumed to be an adverse effect of
co-trimoxazole. The rash improved after co-trimoxazole
was replaced by co-amoxyclav. The patient was able to
tolerate the co-amoxyclav/doxycycline combination and
completed 12 weeks of eradication therapy. At the time of
this writing she was well without evidence of recurrence
or relapse.
Conclusions
B. pseudomallei infections are known for their protean
manifestations, ranging from septicaemia and pneumonia
to asymptomatic infections, localised ulcers or abscesses.
Diabetes has been found to be the single most common
predisposing factor for melioidosis [2,3]. The disease
occurs mainly in rural areas and is associated with
occupational exposure to soil and surface water. In
the majority of cases it probably goes undiagnosed
and untreated.
Our patient had diabetes but she did not have any
known exposure to soil or water. There was no history
of travelling to a known endemic area suggesting that
she had acquired the disease in Sri Lanka and that the
disease is more prevalent than previously thought.
Ten cases [4-10] of melioidosis have been reported in
Sri Lanka; the first, in an English tea broker in 1927.
Most of them were fatal with only 4 survivors [7-10].
Delay in diagnosis may have been a factor contributing
to the high mortality.
In our patient, we actively suspected melioidosis on
the 4th day after admission, when pus culture revealed a
“pseudomonas species” resistant to gentamicin. The fact
that she was still unwell, three months after surgery and
antibiotics for a deep thigh abscess, strengthened our
suspicion. Rapid initiation of appropriate therapy would
have contributed to her good prognosis.
Isolation of B. pseudomallei in culture is essential to
confirm the initial clinical diagnosis. Our patient may
have been diagnosed three months previously if aspirated
pus had been sent for microbiological examination. It is
also important to note that, if the reporting laboratory is
unfamiliar with this bacterium, B. pseudomallei may be re-
ported as “pseudomonas species”. Therefore, if melioidosis
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requested.
Our patient had only intravenous ceftazidime for four
weeks in the acute phase. Combination of co-trimoxazole
with ceftazidime is not recommended in the acute phase
as there is no added benefit [12]. Oral co-trimoxazole and
doxycycline was chosen for the eradication phase of anti-
biotics. They were overlapped with ceftazidime for one
week as this is the vulnerable period where reactivation
can occur [12].
This case illustrates the fact that a high degree of
clinical suspicion is needed to diagnose melioidosis at
an early stage. When culture of patient specimens yields a
“pseudomonas species” which is resistant to gentamicin,
melioidosis should be actively excluded, especially in a
diabetic.
Use of a selective medium such as Ashdown’s agar and
alerting the microbiological community to the characteris-
tic microscopic and colony morphology and resistance
pattern of B.pseudomallei may help to improve the detec-
tion rate of melioidosis in the country.
A long course of intravenous antibiotics in the acute
phase, overlapped and followed by a prolonged course of a
combination of oral antibiotics is needed to improve the
prognosis of this potentially fatal, emerging infection.Consent
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